GB Vert 8mg Tablet contains Betahistine dihydrochloride, an active ingredient indicated primarily for the treatment of vertigo and balance disorders associated with Ménière’s disease. Betahistine acts as a histamine analogue, exerting its therapeutic effect by improving microcirculation in the inner ear, thereby reducing the pressure caused by excessive endolymphatic fluid. This action helps alleviate symptoms such as dizziness, tinnitus, hearing loss, and nausea. GB Vert 8mg is typically administered orally, with dosing tailored according to clinical response and severity of symptoms. The medication is generally well-tolerated; however, mild adverse effects such as gastrointestinal discomfort, headache, or allergic reactions may occur. Betahistine is contraindicated in patients with pheochromocytoma and should be used cautiously in individuals with a history of peptic ulcers. It is essential to adhere to prescribed dosages and consult a healthcare professional before initiating therapy, especially in pregnant or lactating women. GB Vert 8mg Tablet offers an effective pharmacological option for managing vestibular disorders, improving patient quality of life by mitigating vertigo and associated symptoms through its vasodilatory and histaminergic properties.